Published in Neurology on May 10, 2005
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
Migraine and cardiovascular disease: a population-based study. Neurology (2010) 2.51
Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology (2009) 1.14
Relation of candidate genes that encode for endothelial function to migraine and stroke: the Stroke Prevention in Young Women study. Stroke (2009) 0.95
No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet (2006) 0.89
Migraine and cerebral infarction in young people. Neurol Sci (2009) 0.82
Basilar artery occlusion in migraine-like headache: a possible triggering effect of sumatriptan. Neurol Sci (2011) 0.80
Urinary albumin excretion as a marker of endothelial dysfunction in migraine sufferers: the HUNT study, Norway. BMJ Open (2013) 0.78
The Prevalence of Magnetic Resonance Imaging Hyperintensity in Migraine Patients and Its Association with Migraine Headache Characteristics and Cardiovascular Risk Factors. Oman Med J (2015) 0.77
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci (1996) 6.12
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia (2010) 3.54
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet (1999) 2.81
Brain stem activation in spontaneous human migraine attacks. Nat Med (1995) 2.67
Influence of central set on human postural responses. J Neurophysiol (1989) 2.66
Postural strategies associated with somatosensory and vestibular loss. Exp Brain Res (1990) 2.54
Migraine and cardiovascular disease: a population-based study. Neurology (2010) 2.51
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke (2001) 2.45
Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol (1999) 2.36
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
Recovery from Wernicke's aphasia: a positron emission tomographic study. Ann Neurol (1995) 1.86
Dissociation of the lateral and medial cerebellum in movement timing and movement execution. Exp Brain Res (1988) 1.82
Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia (2009) 1.77
Cerebellar control of postural scaling and central set in stance. J Neurophysiol (1994) 1.75
Ab initio determination of light hadron masses. Science (2008) 1.74
Gray matter decrease in patients with chronic tension type headache. Neurology (2005) 1.71
Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia (2009) 1.69
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology (2001) 1.68
Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology (2008) 1.63
Localization of a cerebellar timing process using PET. Neurology (1995) 1.62
[Pain treatment facilities in Germany. Ambulatory, day care and inpatient facilities for patients with chronic pain]. Schmerz (2004) 1.61
Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol (1984) 1.57
Body mass index and mortality in men: evaluating the shape of the association. Int J Obes (Lond) (2007) 1.57
Prevalence of cluster headache in a population-based sample in Germany. Cephalalgia (2007) 1.56
Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia (2007) 1.52
The significance of proprioception on postural stabilization as assessed by ischemia. Brain Res (1984) 1.48
Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke (2000) 1.47
Epidemiology of chronic daily headache. Eur J Med Res (2003) 1.45
Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology (2004) 1.44
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. Eur J Neurol (2009) 1.44
Symptomatic migraine and pontine vascular malformation: evidence for a key role of the brainstem in the pathophysiology of chronic migraine. Cephalalgia (2006) 1.43
[Recent new information on epidemiology of headache]. Fortschr Neurol Psychiatr (2004) 1.42
[Postpoliomyelitis syndrome]. Dtsch Med Wochenschr (1994) 1.39
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology (2011) 1.36
Brain representation of active and passive movements. Neuroimage (1996) 1.36
On the role of vestibular, visual and somatosensory information for dynamic postural control in humans. Prog Brain Res (1988) 1.31
Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol (2002) 1.28
Arm training induced brain plasticity in stroke studied with serial positron emission tomography. Neuroimage (2001) 1.26
Early stabilization of human posture after a sudden disturbance: influence of rate and amplitude of displacement. Exp Brain Res (1984) 1.25
Hypothalamic deep brain stimulation for cluster headache: experience from a new multicase series. Cephalalgia (2008) 1.24
Variability of postural "reflexes" in humans. Exp Brain Res (1983) 1.22
Evolution of functional reorganization in hemiplegic stroke: a serial positron emission tomographic activation study. Ann Neurol (1999) 1.21
Reflex activation of muscle spindles in human pretibial muscles during standing. J Neurophysiol (1990) 1.20
Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol (2008) 1.19
Characteristic alterations of long-loop "reflexes" in patients with Friedreich's disease and late atrophy of the cerebellar anterior lobe. J Neurol Neurosurg Psychiatry (1984) 1.19
Compensatory visual field training for patients with hemianopia after stroke. Neurosci Lett (2001) 1.17
24 hour continuous tremor quantification based on EMG recording. Electroencephalogr Clin Neurophysiol (1989) 1.16
The European Stroke Scale. Stroke (1994) 1.15
Comparison of eyeblink conditioning in patients with superior and posterior inferior cerebellar lesions. Brain (2003) 1.14
Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology (2009) 1.14
Stenosis and occlusion of the subclavian artery: ultrasonographic and clinical findings. J Neurol (1987) 1.12
Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia (2006) 1.11
Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia (2005) 1.10
The relevance of sensory input for the cerebellar control of movements. Neuroimage (1997) 1.10
Follow-up studies of visual potentials in multiple sclerosis evoked by checkerboard and foveal stimulation. Electroencephalogr Clin Neurophysiol (1980) 1.09
Cerebellar dysmetria at the elbow, wrist, and fingers. J Neurophysiol (1991) 1.09
Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J Neurol Neurosurg Psychiatry (1990) 1.08
Differences in clinical characteristics and frequency of accompanying migraine features in episodic and chronic cluster headache. Cephalalgia (2012) 1.08
Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia (2007) 1.07
Reorganization of sensory and motor systems in hemiplegic stroke patients. A positron emission tomography study. Stroke (1999) 1.07
Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia (2007) 1.07
The spatial frequency effect on perceived velocity. Vision Res (1976) 1.06
Behavior of human muscle receptors when reliant on proprioceptive feedback during standing. J Neurophysiol (1990) 1.04
Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant (1999) 1.03
Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology (2010) 1.02
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia (2002) 1.02
Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol (2007) 1.02
Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population. Neurology (2006) 1.01
Guidelines for controlled trials of drugs in tension-type headache: second edition. Cephalalgia (2010) 1.00
Optokinetic-graviceptive interaction in different head positions. Acta Otolaryngol (1975) 0.99
Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet (1997) 0.99
Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab (1999) 0.99
G protein beta3 polymorphism and triptan response in cluster headache. Clin Pharmacol Ther (2007) 0.98
Medium- and long-latency responses to displacements of the ankle joint in patients with spinal and central lesions. Electroencephalogr Clin Neurophysiol (1985) 0.98
Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology (2000) 0.97
Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach. J Thromb Haemost (2006) 0.97
Cortical reorganization in patients with facial palsy. Ann Neurol (1997) 0.97
Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology (2003) 0.96
Tubulointerstitial injury and loss of nitric oxide synthases parallel the development of hypertension in the Dahl-SS rat. J Hypertens (2000) 0.95
Experimental cranial pain elicited by capsaicin: a PET study. Pain (1998) 0.95
[Treatment of tension-type headache. Recommendation of the German Migraine and Headache Society]. Schmerz (1998) 0.95
Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet (1995) 0.95
Occipital nerve stimulation for the treatment of chronic cluster headache - lessons learned from 18 months experience. Cent Eur Neurosurg (2011) 0.94
Focal myopathy induced by chronic heroin injection is reversible. Muscle Nerve (2000) 0.94
Control of isometric finger force in patients with cerebellar disease. Brain (1988) 0.94
Involvement of the human medial cerebellum in long-term habituation of the acoustic startle response. Exp Brain Res (2000) 0.94
Acetylsalicylic acid in the treatment of headache. Cephalalgia (1999) 0.94
ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology (2009) 0.94
No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol (2004) 0.93
Medium and long latency EMG responses in leg muscles: Parkinson's disease. J Neurol Neurosurg Psychiatry (1987) 0.93
Non-motor associative learning in patients with isolated degenerative cerebellar disease. Brain (1999) 0.93
Blood pressure measures and risk of total, ischemic, and hemorrhagic stroke in men. Neurology (2006) 0.93
Migraine-associated risks and comorbidity. J Neurol (2008) 0.92
Long latency EMG responses in hand and leg muscles: cerebellar disorders. J Neurol Neurosurg Psychiatry (1987) 0.92
Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Ther (2000) 0.92